3.8 Article

Should tobacco and alcohol companies be allowed to influence Australia's National Drug Strategy?

Journal

PUBLIC HEALTH RESEARCH & PRACTICE
Volume 27, Issue 2, Pages -

Publisher

SAX INST
DOI: 10.17061/phrp2721714

Keywords

-

Funding

  1. National Cancer Institute, US National Institutes of Health, Grant [R01-CA091021]

Ask authors/readers for more resources

Formation of Australia's National Drug Strategy (NDS) included an extensive consultation process that was open not only to community and public health stakeholders, but also to representatives of the tobacco and alcohol industries. Australia is bound by the World Health Organization Framework Convention on Tobacco Control, which requires governments to protect tobacco control measures from interference by the tobacco industry. NDS consultation submissions made by these conflicted industries are not publicly available for scrutiny. The NDS goals are at odds with the commercial agenda of industries that support regulatory stagnation, oppose and undermine effective action, ignore and distort evidence, and prioritise profits over health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available